Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Indore SEZ exports surge 32 percent on strong pharma demand

Indian Pharma exports expected double to USD 65 billion by 2030: Report

Ruchika Sharma10 Feb 2025 12:30 PM IST

India's pharmaceutical exports are projected to double to USD 65 billion by 2030 and reach an impressive USD 350 billion by 2047, according to a...

Natco Pharma unveils Everolimus tablets 1mg in US

Natco Pharma gets final approval for Bosentan tablets for oral suspension

Ruchika Sharma10 Feb 2025 11:30 AM IST

Hyderabad: NATCO Pharma Limited has announced final approval of its Abbreviated New Drug Application (ANDA) for Bosentan tablets for oral...

Novartis Chief Jeffrey Legos to join Pfizer as Chief Oncology Officer

Ruchika Sharma9 Feb 2025 12:30 PM IST

New York: Pfizer Inc. has announced that Jeffrey Legos, PhD, MBA, will join the company as Chief Oncology Officer. In this role, Dr. Legos will...

Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal

Merck begins trial evaluating Zilovertamab Vedotin for previously untreated Diffuse Large B-Cell Lymphoma

Ruchika Sharma9 Feb 2025 10:30 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of waveLINE-010, a pivotal Phase 3 clinical trial...

JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatment

Aurobindo Pharma to acquire 26 percent stake in solar energy company

Ruchika Sharma8 Feb 2025 5:31 PM IST

Telangana: Aurobindo Pharma has announced that the Company will be investing Rs.10.40 crores to acquire 26 percent equity and other securities of...

Cipla gets VAI status for Virgonagar facility

Ruchika Sharma8 Feb 2025 1:30 PM IST

Mumbai: Cipla has announced that the United States Food and Drug Administration (USFDA) has classified the inspection at the Company’s manufacturing...

Indegene opens new center in Pune, boosts India presence

Indegene launches new entity in Spain

Ruchika Sharma8 Feb 2025 12:30 PM IST

Bengaluru: Indegene, a digital-life sciences commercialization company, has announced the launch of a new entity in Spain."This move marks a key step...

USFDA approves AbbVie giant cell arteritis drug Rinvoq in adults

AbbVie gets USFDA nod for Emblaveo for treatment of adults with complicated intra abdominal infections with limited or no treatment option

Ruchika Sharma8 Feb 2025 11:30 AM IST

North Chicago: AbbVie has announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO (aztreonam and avibactam), as a...

Dr Reddy's Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Ruchika Sharma7 Feb 2025 1:30 PM IST

Hyderabad: Dr Reddy's Laboratories SA, a wholly-owned subsidiary of Dr. Reddy's Laboratories Ltd. has announced that it has entered into a ...

Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue Sarcoma

Ruchika Sharma7 Feb 2025 12:30 PM IST

Mumbai: Sun Pharmaceutical Industries Limited and Philogen S.p.A. have announced the successful completion of patient enrollment in the Phase III...

Biocon unveils Liraglutide for diabetes, obesity in Netherlands

Biocon, Equillium announce positive data from Phase 2 Study evaluating Itolizumab for Ulcerative Colitis

Ruchika Sharma7 Feb 2025 11:30 AM IST

Bengaluru: Equillium, Inc., a clinical-stage biotechnology company and Biocon Limited, an innovation-led global biopharmaceutical company, have...

Chemist shop owner among three arrested in Ghaziabad over illegal sale of cancer drugs

Banned cough syrup worth Rs 30 lakh seized in Tripura, 9 arrested

Ruchika Sharma6 Feb 2025 2:30 PM IST

Agartala: 1,500 bottles of banned cough syrup worth Rs 30 lakh have been seized by a joint team of GRP and RPF from Agartala railway station...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok